Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Beta Bionics (BBNX) Operating Margin (2024 - 2025)

Beta Bionics (BBNX) has disclosed Operating Margin for 2 consecutive years, with 50.2% as the latest value for Q4 2025.

  • Quarterly Operating Margin rose 1358.0% to 50.2% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 71.5% through Dec 2025, down 202.0% year-over-year, with the annual reading at 71.5% for FY2025, 202.0% down from the prior year.
  • Operating Margin hit 50.2% in Q4 2025 for Beta Bionics, up from 62.54% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 50.2% in Q4 2025 to a low of 105.69% in Q1 2025.